Amisulpride: all 53 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Amisulpride Injection for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic SurgeryNot yet recruitingNCT07891312Not applicable
- Application of Multimodal Intervention in the Prevention of Postoperative Nausea and Vomiting After Gynecological Laparoscopic SurgeryNot yet recruitingNCT07631910Not applicable
- Characterizing Drug Liking During Drug Administration in Peri-procedural Clinical SettingsNot yet recruitingNCT07348172Early Phase 1
- Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic DepressionCompletedNCT04876521Phase 4Results posted
- Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia NervosaCompletedNCT04128683Early Phase 1Results posted
- Thorough QT Study of Intravenous AmisulprideCompletedNCT02661594Phase 1Results posted
- Study of APD421 as PONV Treatment (Prior Prophylaxis)CompletedNCT02646566Phase 3Results posted
- Study of APD421 as PONV Treatment (no Prior Prophylaxis)CompletedNCT02449291Phase 3Results posted
- Phase IIIb Study of APD421 in Combination as PONV ProphylaxisCompletedNCT02337062Phase 3Results posted
- US Phase III Study of APD421 in PONVCompletedNCT01991860Phase 3Results posted
- European Phase III Study of APD421 in PONVCompletedNCT01991821Phase 3Results posted
- An Investigation of Early Life Stress and DepressionCompletedNCT01701258Phase 1Results posted
- Phase II Dose-ranging Study of APD421 in PONVCompletedNCT01510704Phase 2Results posted
- The Effects of Dopamine on Reward ProcessingCompletedNCT01253421Phase 1Results posted
- An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive SymptomsWithdrawnNCT05956600Not applicable
- A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV.Status unknownNCT05822713Phase 3
- Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric PatientsCompletedNCT05546359Phase 2/3
- PK Study of IV and Oral Amisulpride in Subjects With Severe Renal ImpairmentCompletedNCT04849650Phase 1
- Psychobiological Mechanisms Underlying Chronic PainCompletedNCT04674670Not applicable
- Study on the Gut Microbial Mechanism of Negative Symptoms of SchizophreniaStatus unknownNCT04533724Early Phase 1
- Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model BuildingStatus unknownNCT04446234Phase 4
- Amisulpride Treatment for BPSD in AD PatientsStatus unknownNCT04341467Not applicable
- Influence of Dopaminergic Blockade on Stress Responses, Motivation and Emotional Reactivity in Humans.CompletedNCT03863691Not applicable
- Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination TherapyCompletedNCT03652974Phase 4
- Study of APD421 With and Without OndansetronCompletedNCT03583489Phase 1
- Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)CompletedNCT03510325Phase 3
- [18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in PsychosisStatus unknownNCT02880995Not applicable
- Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward ImpulsivityCompletedNCT02557984Not applicable
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
- Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic PatientsCompletedNCT02307396Phase 4
- Association of Amisulpride Response in Schizophrenia With Brain ImageStatus unknownNCT02095938Phase 4
- Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction StudyCompletedNCT02051387Phase 1
- Effectiveness and Safety of Amisulpride in Chinese Patients With SchizophreniaCompletedNCT01795183Phase 4
- A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of SchizophreniaTerminatedNCT01615185Phase 4
- Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to MonotherapyCompletedNCT01609153Phase 4
- Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site CopenhagenCompletedNCT01555814Not applicable
- Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia PatientsWithdrawnNCT01448499Not applicable
- Bergen Psychosis Project 2 - The Best Intro StudyCompletedNCT01446328Phase 4
- Phase II Proof-of-concept Study of APD421CompletedNCT01303978Phase 2
- Amisulpride Augmentation in Clozapine-unresponsive SchizophreniaCompletedNCT01246232Phase 4
- Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)CompletedNCT01154829Not applicable
- Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic SyndromeCompletedNCT00956189Not applicable
- Tardive Dyskinesia and Cognitive FunctionCompletedNCT00926965Phase 4
- Efficacy Study on Cognitive Functions in Schizophrenic PatientsCompletedNCT00761670Phase 4
- Benzamide Derivates as Treatment of Clozapine-induced HypersalivationCompletedNCT00534573Phase 3
- Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive BehaviorsCompletedNCT00471588Phase 1
- Amisulpride in Schizophrenic Acute Phase PatientsCompletedNCT00436371Phase 4
- Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological TherapyTerminatedNCT00419653Phase 4
- Amisulpride in Schizophrenic PatientsCompletedNCT00331981Phase 4
- SWitching to Abilify Trial (SWAT)CompletedNCT00304616Phase 4
- SOLIACS: Solian Solution in the Acute SettingCompletedNCT00245674Phase 4
- Early Pharmacological and Psychological Intervention for Late Prodromal States of PsychosisCompletedNCT00204061Phase 4
- SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I PatientsCompletedNCT00126009Phase 2